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• Although hypothermia as a means of neuronal 
protection and resuscitation after ischemic damage has a 
history of approximately four decades, extensive studies on 
the mechanisms, effects and methods of mild hypothermia 
at no less than 32°C have been started only in the last 
decade, both in basic and clinical fields. In experiments on 
rodents, postischemically introduced hypothermia, even as 
late as several hours after reperfusion, which was main 
tained for one day followed by a slow rewarming, definitely 
rescued hippocampal neurons against damage. Hypother 
mia appears to have a much greater potential for cerebral 
resuscitation than any chemical proposed so far for this 
purpose. The mode of action of hypothermia is apparently 
nonspecific and multifocal in widely progressing cascade 
reactions in ischemic cells, including (i) suppressing 
glutamate surge followed by (ii) intraneuronal calcium 
mobilization, (Hi) postischemic sustained activation of 
glutamate receptors, (iv) dysfunction of blood-brain bar 
rier, (v) proliferation of microglial cells, and (vi) produc 
tion of superoxide unions and nitric oxide in microglial 
cells, and of activator protein-1 in ischemically vulnerable 
regions like hippocampal CA1. Recent clinical trials of mild 
hypothermia have revealed significantly beneficial out- 
Received for publication 20 October 1997 and accepted 15 November 
1997. 
Corespondence and reprintrequests to DrKiyoshi Kataoka, Department 
of Physiology, Ehime University, School ofMedicine,Shigenobu, Onsen- 
gun,Ehime791-02,Japan,Tel: 89(89)9605241,Fax: 89(89)9605242. 
comes along with an accumulation of knowhows on various 
techniques and treatments. Large scale randomized studies 
involving multiple institutions as well as exchanging ideas 
are needed for further development of hypothermia 
treatment. (Biomed Rev 1997; 8: 23-36) 
INTRODUCTION 
• More than half a century has passed since human 
refrigeration was first introduced (1). Soon afterwards, the 
potential use of hypothermia for neuronal protection and 
resuscitation has been suggested from both experimental and 
clinical researches (2, 3). However, a variety of confounding 
side effects, such as cardiovascular dysfunction, and severe 
infections, have hindered hypothermia from being firmly 
established as a treatment for brain injury or stroke (4-9). 
Moreover, a lack of animal studies has resulted in little basic 
information on when, to what degree, or how long body tem 
perature can be safely lowered and maintained. This might be 
another reason for hesitations on the hypothermic treatment. 
It was only a decade ago when a milestone report for hypo 
thermia appeared on experiments with rodents in which slight 
lowering of body temperature to 33°C produced a marked 
protection of central neurons against ischemic damage (10). 
This report would be a signal fire for the second wave of human 
hypothermia for protection or resuscitation of ischemic brain. 
Since then, basic experiments have been widely carried out on 
the rat (11-28), and the gerbil (29-35). In these models, it is 
confirmed that mild hypothermia, even when introduced as 
late as several hours postischemia, is significantly more 
effective than any chemical proposed so far for protection of 
  
  
neurons against ischemic degeneration (36-45). At the same 
time, clinical applications of mild hypothermia for patients in 
acute stages of brain injury or stroke have been performed, 
mainly in the USA and Japan (46-55). Although the mentioned 
side effects and limitations of application are still problems to 
be solved, indications for anesthesia, applicable clinical 
conditions, methods for temperature lowering, maintenance 
and rewarming, monitoring, and countermeasures for side 
effects have been steadily developed (56). 
In this review, we briefly summarize the development and 
technique of hypothermia treatment for ischemic brain injury, 
and discuss the problems to be solved on both basic and 
clinical fields. 
HISTORICAL BACKGROUND OF HUMAN 
REFRIGERATION 
• Local cooling of the body surface have been widely 
employed as a folk remedy since the earliest days of medi 
cine. Hippocrates in Cos described the usefulness of local 
cooling with snow and ice before operation for its analgesic 
nature (57). However, it was little more than half a century ago 
when whole body cooling was first introduced, thus opening 
the new era of human refrigeration as a clinical countermea- 
sure (1, 58). These authors put forth the idea that when body 
temperature is lowered, proliferation of malignant tumors and 
hence development of tumorigenic pain might be suppressed. 
In some cases, they designed a brain probe which was con 
nected to a refrigerator. Since their first patient in 1938, 169 
cases in total were treated by hypothermia, with a mortality at 
11.2%. Considering that all patients were in the terminal stage 
of their cancers, and that medical treatments were less mod 
ernized and antibiotics were not available, this pioneering 
work appears to have had a satisfiable and encouraging out 
come. The degree was generally 33°C, but some cases were as 
low as 22°C. Fay (59) summarized from these experiments 
that the reversible limit of hypothermia was 24°C, and that 
hypothermia at 29-32°C could be maintained for 10 days, a 
surprising result from the present standpoint. Soon after 
wards, Talbott (60) applied prolonged total body hypothermia 
to schizophrenia patients, and obtained striking and sustained 
improvements in 4 out of 10 trials. Further, McQuiston (61) 
proposed a total body cooling during operations on children 
with heart disease, and Bigelow et al (62) confirmed that 
hypothermia at 20°C reduced oxygen demand, cardiac output 
and metabolic rate to 15% of their values at normal tempera 
ture. Based on these findings, the possibility of open chest 
surgery under hypothermic conditions was strongly suggested 
(63). To explore this possibility, Parkins et al (64) installed 
a cooling bypass at the common carotid artery in dogs, in order 
to selectively cool down the cerebral circulation, and then 
examined the critical temperature at which central dysfunc 
tion began to occur; the dogs could tolerate hypothermia up 
to 12°C, and subsequently recovered without any failure of 
higher functions. Rosomoff and Holaday (65) analyzed the 
cerebral blood flow and oxygen consumption of dogs and 
found that both were reduced by 6.7% for every 1°C decrease in 
the temperature range of 25-35°C. It was shown that occlusion of 
the middle cerebral artery produced smaller cerebral 
infarctions at lowered temperature, which appears the first 
report on the brain resuscitating capability of hypothermia 
(66). Hence, a question was raised as what was the minimum 
temperature that mammals could tolerate (67); Gollan et al 
showed that dogs could survive cooling to 1.5°C (68). In 
1955, a symposium entitled "The Physiology of Induced 
Hypothermia" was held in the USA, where wide range of basic 
findings were presented and discussed (69-71). Clinical studies 
were also described, wherein a significant reduction in 
paraplegia was obtained after surgical dissection of thoracic 
aorta aneurysms under hypothermia, while high indices of 
spinal cord damage were observed under normothermic 
operation in similar cases (72). Hirsch and Muller (73) made 
a rabbit model for transient global ischemia, and found that, 
histologically, the full resuscitation of cerebral neurons was 
obtained even after 40 min of ischemia at 25°C, while only 8-10 
min was acceptable at the normal temperature. Two reports 
strongly suggested to us the ability of hypothermia to protect or 
resuscitate the brain in humans; both were 5 years old boys in 
Norway, who drowned in a frozen river or lake, one for 22 min 
(74), the other for 40 min (75), before being rescued and 
transported to the hospital. Both patients had no vital signs for 
more than 2-3 hours, but showed gradual recovery in intensive 
care over the next few days, and finally left the hospital without 
any central disturbances; rectal temperature in the second case 
was 24°C at the time of the rescue (75). At this temperature, 
cerebral blood flow, heat production, and ATP expenditure 
should be much less than those at normal temperature, and there 
should be virtually no firing of neurons, creating a state very 
similar to deep anesthesia. Other reports also described 
beneficial cerebral effects of hypothermia, which attracted 
considerable attention to the possibility of introducing 
hypothermia into clinical use as a treatment for cerebral 
injuries (76-80). There has been a growing body of evidence 
which indicates that hypothermia protects the brain against the 
harmful effects of a reduction in oxygen supply (81-84), 
barbiturate showing a similar protection (85, 86). The 
suggested mechanism was that hypothermia shifts the 
oxyhemoglobin dissociation curve to the left, preventing a 
rightward shift as result of acidosis, which could maintain a high 
arterial TO2 at a given PaO2, and a reduced CMRO2 along with 
decreased , cellular energy requirement (84). 
• Small animal models of ischemia  
As described in the previous section, a report by Busto et al 
(10) has opened a second era for hypothermia studies. They j 
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observed in a four-vessel-occlusion model of the rat that 
lowering of body temperature by 2-4°C resulted in a significant 
resuscitation of hippocampal CA1 neurons, known to be 
extremely vulnerable to ischemia, in contrast to the delayed 
neuronal death that occurred at 37°C (87). In spite of the 
cerebral protection provided by hypothermia, hyperthermia 
was clearly shown to increase damage in a transient ischemic 
model of the rat (13). Using a slightly different model, these 
authors discovered that extremely temperature sensitive areas 
existed in brain such as the caudatoputamen, while the lateral 
reticular nucleus of the thalamus was less temperature sensitive 
(12). A large number of investigations have demonstrated that 
intraischemic hypothermia, i.e. hypothermia introduced and 
maintained during the ischemic insult, diminishes neuronal 
damage and improves recovery following transient global (17, 
20, 29, 32, 33, 35) and focal (16, 18, 19, 21, 22, 24, 25, 27, 
28, 88) ischemia as well as trauma (89). Colbourne and 
Corbett (42) employed a long-term recording system for 
brain temperature in a gerbil model with a transient occlusion 
of the common carotid arteries for 5 min, which produced 
delayed neuronal death in hippocampal CA1 four days after 
the operation. These authors also established that a postis-
chemic hypothermia introduced even as late as 4 hours after 
reperfusion at 34°C and maintained for 24 hours, could 
resuscitate CA1 neurons for at least 180 days of survival (43). 
This finding confirmed that at least in these animal models, 
postischemic mild hypothermia could resuscitate neurons 
that would otherwise die, in a delayed fashion for considerably 
long time (Table 1). These may encourage colleagues in the 
clinical field who are interested in the introduction of 
hypothermia. A suggestion that hypothermia could only shift 
the time of death of neurons to some days afterwards, was 
based on a rather special case of a duration of hypothermia being 
too short (20). Permanent ischemia models on the rat have 
also been employed for the test of hypothermia. The outcome 
of hypothermia was partly positive, while other tests were not 
significantly different from non-ischemic controls (15, 18, 
36, 39, 44); these are summarized in Table 2. 
MODE OF ACTION OF HYPOTHERMIA 
• As was shown in hypothermic animals or animals in 
hibernation, metabolic rate was remarkably reduced at lower 
ed temperature (62, 67, 90, 91); this may explain the incre 
ased resistance of ischemic neurons to damage at lowered 
temperature. However, the degree of reduced oxygen and 
glucose demand at lowered temperature should always over 
come the degree of shortness of demand of these substances. 
There are many modes of ischemic neuronal death, and many 
details are still unknown (Fig. 1). At the very initial stage of 
ischemia, excitotoxicity plays a pivotal role (92, 93), where a 
large-scale glutamate surge (94) due to dysfunction of glutamate 
transporters is induced within 20-30 seconds after the start of 
ischemic insult in hippocampal CA1 of the gerbil (33). The 
extracellular glutamate level sometimes exceeds 20 and 100 
times the basal levels, at 5 and 10 minutes after ischemia, 
respectively (95). In response to the glutamate surge, an in-
tracellular calcium mobilization follows within 2-3 min after 
ischemic insults (96, 97). This calcium mobilization is lethal 
when it is sustained and exceeds beyond certain levels (98, 
99), because calcium damages mitochondrial respiration and 
induces calcium dependent cascade reactions in an 
uncontrolled manner. When ischemic insults were 
performed at lowered temperature, the degree of glutamate 
surge is largely depressed (33, 100) and the onset of calcium 
mobilization is significantly delayed (101). In the delayed death 
model of the gerbil hippocampal CA1, neurons are resuscitated 
in a half of the animals at 35°C, and totally resuscitated at 
33°C (33). However, in these gerbil models, excitotoxicity 
will entirely finish within one hour after the ischemic insults, 
while postischemic hypothermia introduced some hours after 
the insults still resuscitates hippocampal neurons as effectively 
as prior hypothermia (Fig. 2) (37, 41-43, 45). This finding 
indicates that temperature dependent cell processes are still 
going on after excitotoxicity. Here we should pay much 
attention to post-excitotoxic connections. One such 
connection should be the postischemic sustained activation of 
glutamate receptors. When hippocampal slices were 
subjected to a micro-fluorometry imaging for intracellular 
changes of calcium concentration, a mobilization of calcium 
in response to the addition of N-methyl-D-aspartate 
(NMDA), an agonist for glutamate receptors, was clearly 
demonstrated selectively in the strata radiatum and oriens of 
the ischemically vulnerable CA1 sector in an in vitro ischemic 
condition. In this model, the calcium responses to the NMDA 
addition were found to significantly increase in gerbils that 
had been subjected to transient ischemic insults for 5 min 1 to 
9 hours, with a peak around 3-6 hours, before sacrifice 
(102). This apparently sustained activation of NMDA type 
glutamate receptors can be further confirmed by a patch clamp 
study on CA1 neurons in hippocampal slices of the gerbil (103). 
Thus, it was shown that practically no such sustained 
enhancements of the calcium mobilization could be detected 
in slices from gerbils that were subjected to the transient 
ischemia at lowered brain temperature around at 33°C (102). 
Dramatic changes develop in ischemic neuron nuclei. It has 
been known that protein synthesis is almost totally and 
irreversibly depressed in the CA1 sector; that is a key 
mechanism of the delayed neuronal death (104). When the 
insults were performed at 30°C in a four-vessel-occlusion 
model of the rat, there could be seen an earlier recovery of the 
synthesis of protein along with neuronal survival in the CA1 
(105, 106). Also, a marked enhancement of DNA binding 
ability of a transcription factor, activator protein-1 (AP-1), in 
gerbil hippocampus was found (107). In these cases, 







Figure 1. Illustration of ischemic neuronal death. When the brain is exposed to ischemia, an immediate glutamate release occurs from presynaptic 
neurons followed by postsynaptic neurons and then glial cells. The extracellular glutamate surge induces a marked Ca2+ mobilization in neurons via 
glutamate receptors, which induces various Ca2+-dependent cascade reactions. Not only neurons, but also astrocytes and microglial cells are profoundly 
affected by ischemic insult. Cerebral protection by hypothermia might be based on its non-specific widely progressing reactions in the whole ischemic entity 
shown in this figure (*).Glu, glutamate; Gin, glutamine; VDCC, voltage dependent Ca2+ channel; A/K-R, AMPA-kainate type glutamate receptor; NMDA-R, 
NMDA type glutamate receptor; Met-R, metabotropic glutamate receptor; G, G-protein; PLC, phospholipase C; PIP, phosphatidylinositol phosphate; IPy 
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hippocampus, there were significant differences among the 
CA1, CA3 and dentate gyrus, including CA4, in terms of 
temporal profiles of the DNA binding activities; e.g. the time 
courses for the activity was prolonged from 1 to 9 hours in the 
CA3 and the dentate gyrus, while a rather short-lived 
enhancement was observed in the CA1, the area vulnerable to 
ischemia (108). However, gerbils with prior ischemic insults at 
32°C, showed a prolonged period of binding activation, 
becoming closer to the profiles for ischemia-resistant CA3 and 
dentate gyrus. Similar prolongation can be seen in gerbils 
which are rendered resistant to ischemic insult by a prior 
loading with a short ischemic insult for 2 min (109). 
Although the protein which will be synthesized after AP-1 
binds to an upstream region of the corresponding gene is still 
unidentified, it is not likely linked to protection resuscitation of 
deteriorating neurons. 
In the rat middle cerebral artery occlusion model, a 
postischemically induced hypoperfusion followed by a 
hyperper-fusion disappeared when the operations were 
carried out in hypothermic conditions (110). Cerebral edema 
and failure of the blood-brain barrier, which are both 
pathophysiological events resulting from ischemia, can also 
be depressed by hypothermia. Although the knowledge of 
the cellular processes after ischemia is still only fragmentary , 
particularly of 
late phenomena after excitotoxicity, it is very likely that there is 
a multiplicity of cascade reactions which proceed both in 
temporal and spatial ranges. Endothelial cells as well as 
astroglial and microglial cells participate in the ischemic 
processes. In this relation, we have recently found an 
involvement of albumin in the ischemic response of microglial 
cells. When cultured microglial cells were exposed to a 
minute concentration of albumin, the cells remarkably 
proliferated, and significantly increased both phorbol ester-
induced production of superoxide anions and 
lipopolysaccharide-induced formation of nitric oxide (111). It 
is known, that superoxide anions themselves and the product of 
their reaction with nitric oxide are harmful to neurons. In effect, 
it may be possible that, when albumin leaks out through the 
postischemically deteriorated blood-brain barrier, it starts to 
stimulate microglial cells to proliferate, which then induces 
production of super-oxide as well as nitric oxide by these cells, 
causing damage to ischemic neurons. Proliferating microglial 
cells could be seen in the immediate proximity of neurons 
shortly after onset of ischemic insult (112, 113). These 
findings suggest that microglial cells in ischemic conditions 
play a role as a damage inducer to neurons, although they 
behave as scavengers after neurons die. However, 
postischemic hypothermia depresses microglial proliferation 
(unpublished data). It is intriguing that cultured microglial 




Figure 2. Photomicrographs of sections of gerbil hippocampus. Animals were sacrificed after 30 days of survival following 
5 min of bilateral carotid artery occlusion, (a) and (d)are non-ischemic animals. In normothermic animals (b, e), there is a 
widespread neuronal destruction in CA1 sector, while almost all neurons in CA3 and dentate gyrus are preserved. In 
postischemically hypothermic animals (c, f) (hypothermia was initiated 1 h after the ischemic insult and maintained for 24 
h), most neurons in CA1 sector are preserved, d, e, and f are higher magnifications of a portion ofCAl sector. Bars, 500 um 
(a, b, c), and 50 um (d, e, f) . 
  
  
oxide anions and nitric oxide at a temperature lower than 37°C 
(114). 
Elucidation of mechanism of ischemic neuronal damage should 
lead to the development of drugs based on blocking or 
modifying these cellular processes. A variety of chemicals 
have been proposed in this regard so far for the possible 
clinical treatment of ischemic neuronal damage in stroke, 
injury, and transient cardiopulmonary arrest. Studies on 
excitotoxicity (92, 93, 115, 116) showed that the extracellu 
lar glutamate surge following ischemic insult might activate 
the receptors strongly and sustainedly. Molecular biological 
approaches have indicated that NMDA type glutamate recep 
tors are, when activated in ischemic condition, highly at risk, 
since the receptor-associated channels open for not only 
monovalent cations but also for calcium ions, which induces 
a deadly mobilization of intracellular calcium (2, 3, 98, 99). 
Although glutamate antagonists of both NMDA and non- 
NMDA type receptors have been studied in the CA1 sector of 
the hippocampus because of its extraordinary vulnerability to 
ischemic insults, a non-competitive antagonist of NMDA 
receptors, (+) -5-methyl-10, 1 l-dihydro-5H-dibenzo [a, d] 
cycloheptene-5, 10-imine maleate (MK-801) has attracted 
attention for its strong protective effect against ischemic 
damage of CA1 neurons at low doses (117, 118). However, 
later, the beneficial effect of MK-801was disputed as it was 
proved that the apparent neuroprotective action of MK-801 
was not through its pharmacological properties, but through 
its temperature-lowering activity (30, 119, 120). Therefore, 
there has been a considerable controversy on whether MK- 
801 actually protects ischemic neurons, and the notion has 
been raised that studies on small animals to evaluate any 
chemical for its neuroprotective potential should include 
analysis for its effect on brain temperature when adminis 
tered. As far as we were aware of this, a large number of 
chemicals reported to be neuroprotective have been found to 
be much less active than described, even inactive, when re- 
evaluated in our experimental paradigm. Thus, we have de 
signed a telemeter-based brain temperature control system 
that allows continuous monitoring and regulation of brain 
temperature at any selected degree in conscious and freely 
moving animals (121). Using this instrument, we can control 
brain temperature in a narrow range around at 37°C, and 
observed a selective, delayed neuronal death in hippocampal 
CA1 of gerbils that were subjected to a global cerebral is 
chemia for 5 min. The following outcomes were then ob 
tained: CA1 neurons could certainly survive from ischemic 
damage on the intraperitoneal administration of MK-801 only 
at doses of more than 10 mg/kg, much higher than those 
employed in the previous studies, which, showing similar 
survival on 1-3 mg/kg, had no brain temperature control at all 
(120). . 
CLINICAL HYPOTHERMIA UPDATE 
• Three randomized control studies of mild hypother 
mia in patients with severe closed-head injury were indepen 
dently reported in 1993. They all revealed beneficial effects. 
When hypothermia was introduced at 32°C to 33°C within a 
mean of 10 hours after injury and maintained for 24 hours 
followed by a slow rewarming, a significant reduction of 
intracranial pressure as well as cerebral blood flow during the 
cooling period was obtained without any rebound (49). Twelve 
of the 20 patients in the hypothermia group showed outcome 
of moderate, mild or no disabilities, while 8 of the 20 patients 
did in the normothermia group (49). When hypothermia was 
introduced at 34°C for 2 days followed by a slow rewarming, 
a significant reduction of cerebral perfusion pressure was 
demonstrated (50). Eight of 16 patients survived in the hy 
pothermia group, while 3 of 17 patients survived in the normo 
thermia group (50). Clifton et al (46) demonstrated that after 
3 months, the ratio of patients with less than moderate disabil 
ity to patients with more severe disability was 12 to 11 in the 
group where hypothermia was introduced within 6 hours at 32- 
33°C for 2 days followed by a slow rewarming, and 8 to 14 in 
the normothermia group. 
Recently in Japan, a research project chaired by one of the 
authors (K.K.), entitled "Mild hypothermia for a treatment of 
stroke - basic investigations and clinical studies" has been 
organized in the 1994-1996 fiscal year under the support of 
the Ministry of Health and Welfare. Although studies should be 
extended further, the project made the following contemporary 
consensus at the conclusion of the project (56): hypothermia 
can be applied to patients with brain injury, cerebral infarction, 
subarachnoidal bleeding (after clipping) and transient 
cardiopulmonary arrest in their very acute stage. Basic 
intensive control of general and cerebral circulation with 
sufficient oxygen supply should be secured. For anesthesia, 
the use of midazolam (GABA agonist) or droperidol (a-
adrenergic blocker) is recommended. Systemic blood 
pressure, cerebral perfusion pressure and oxygen supply should 
be more than 100 mmHg, 80 mmHg and 800 ml/min, 
respectively. Oxygen consumption rate and intracranial 
pressure should be less than 25% and 20 mmHg, 
respectively. Brain temperature could be kept at 33-34°C, 
while 35°C is recommended for less experienced institutions. 
The use of a blanket for surface cooling, with occasional 
intragastric cooling, is suggested. Intracerebral temperature 
is to be monitored by intrajugular temperature measurement, 
with occasional monitoring of the temperature of the tympanic 
membrane, urinary bladder or pulmonary vein. The period of 
hypothermia is not to be limited. However, occasional severe 
infections should be carefully and intensively controlled. 
Rewarming should he slowly performed, for instance at the 
rate of 0.1 °C per hour with a sustaining period at 35°C. Cardiac 
output and the oxygen   
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saturation ratio of mixed venous blood should be monitored 
with a Swan-Ganz catheter. Platelet transfusion and suplemen-
tation of potassium may be occasionally needed, and 
hemoglobin content in blood stream should be kept at greater 
than 12 g/dl. In addition to these clinical suggestions, the 
project emphasized the need to organize large-scale randomized 
studies involving different institutions exchanging 
information and ideas, in the overall prospects for future 
improvement of hypothermia treatment. 
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